Millions of Americans have used GoodRx, a drug discount app, to search for lower prices on prescriptions like antidepressants, H.I.V. medications and treatments for sexually transmitted diseases at their local drugstores. But U.S. regulators say the app’s coupons and convenience came at a high cost for users: wrongful disclosure of their intimate health information.On Wednesday, the Federal Trade Commission accused the app’s developer, GoodRx Holdings, of sharing sensitive personal data about users’ prescription medications and illnesses with companies like Facebook and Google without authorization.The company’s information-sharing practices, the agency said, violated a federal rule requiring health apps and fitness trackers that collec …
Latest Business News
Regenerative Agriculture: Restoring Ecosystems While Increasing Productivity (6/12/2026) - Full session recording featuring Monica McBride of Bayer and Tom… Read more...
Can AI Improve Global Health Without Trust, Equity, and Accountability? (6/10/2026) - Full session recording featuring David Lazerson of Briya and Jonathan… Read more...
The New Architecture of Value (6/8/2026) - Full session recording featuring Amy Terpeluk and Gil Bashe of… Read more...
The Emergence of Decision Trust Infrastructure: Why Defensible AI Is Now a Board-Level Conversation (6/5/2026) - 1BusinessWorld • 1ArtificialIntelligence The Emergence of Decision Trust Infrastructure Chiru… Read more...
Regulating Innovation: How Policy is Reshaping the Future of Health (6/5/2026) - Full session recording featuring David Farber of King & Spalding… Read more...
From Innovation to Impact: Rewiring Health Delivery for the AI Era (6/4/2026) - Full session recording featuring Arturo LoAIza-Bonilla joining host Fern Lazar… Read more...
AI and Cloud Security in the Age of Enterprise Autonomy (6/3/2026) - AI and Cloud Security in the Age of Enterprise AutonomyAI… Read more...
What It Takes to Bring Clinical AI into Real Practice (5/30/2026) - Full session recording featuring Junmyung Kwon, Founder and CEO of… Read more...